AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Basal-like breast cancer (BLBC) is associated with high-grade, distant metastasis and poor prognosis. Elucidating the determinants of aggressiveness in BLBC may facilitate the development of novel interventions for this challenging disease. In this study, we show that aldo-keto reductase 1 member B1 (AKR1B1) overexpression highly correlates with BLBC and predicts poor prognosis in breast cancer patients. Mechanistically, Twist2 transcriptionally induces AKR1B1 expression, leading to nuclear factor κB (NF-κB) activation. In turn, NF-κB up-regulates Twist2 expression, thereby fulfilling a positive feedback loop that activates the epithelial–mesenchymal transition program and enhances cancer stem cell (CSC)–like properties in BLBC. AKR1B1 expression promotes, whereas AKR1B1 knockdown inhibits, tumorigenicity and metastasis. Importantly, epalrestat, an AKR1B1 inhibitor that has been approved for the treatment of diabetic complications, significantly suppresses CSC properties, tumorigenicity, and metastasis of BLBC cells. Together, our study identifies AKR1B1 as a key modulator of tumor aggressiveness and suggests that pharmacologic inhibition of AKR1B1 has the potential to become a valuable therapeutic strategy for BLBC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196 · cited 1×
“Several transcription factors, such as Snail, Twist1/2, and Zeb1/2, have been implicated in the transcriptional repression of E-cadherin and the induction of EMT (Yang et al., 2004; Kalluri and Weinberg, 2009; Thiery et al., 2009).”
BackgroundEpithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302 · cited 5×
“Notably, BLBC possesses the activated epithelial–mesenchymal transition (EMT) program, which is required for tumor progression and metastasis (Mani et al., 2008; Gupta et al., 2009; Polyak and Weinberg, 2009; Valastyan and Weinberg, 2011; Dong et al., 2013b).”
BackgroundInfluentialGenes that mediate breast cancer metastasis to the brain
Bos, P. D., Zhang, X. H.-F., Nadal, C., Shu, W., Gomis, R. R., Nguyen, D. X., Minn, A. J., van de Vijver, M. J., Gerald, W. L., Foekens, J. A., et al. (2009) · Nature · doi:10.1038/nature08021 · Cited by 1,863
Zhou, B. P., Deng, J., Xia, W., Xu, J., Li, Y. M., Gunduz, M., & Hung, M.-C. (2004) · Nature Cell Biology · doi:10.1038/ncb1173 · Cited by 1,581 · cited 2×
“4 H). relA transcriptionally induces twist2 expression The NF-κB pathway has been implicated in the regulation of EMT (Huber et al., 2004; Zhou et al., 2004).”
BackgroundHatzis, C. (2011) · JAMA · doi:10.1001/jama.2011.593 · Cited by 699 · cited 2×
“GSE25066 and dataset NKI295), which contain 508 and 295 breast cancer patients, respectively (van de Vijver et al., 2002; Hatzis et al., 2011).”
BackgroundInteraction with Suv39H1 is critical for Snail-mediated E-cadherin repression in breast cancer
Dong, C., Wu, Y., Wang, Y., Wang, C., Kang, T., Rychahou, P. G., Chi, Y.-I., Evers, B. M., & Zhou, B. P. (2013) · Oncogene · doi:10.1038/onc.2012.169 · Cited by 214
Self-citation
Cited by
Zhou, H.-M., Zhang, J.-G., Zhang, X., & Li, Q. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00430-1 · Cited by 472
Hu, J., Zhang, L., Xia, H., Yan, Y., Zhu, X., Sun, F., Sun, L., Li, S., Li, D., Wang, J., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01164-9 · Cited by 373
Bioactive lipids, inflammation and chronic diseases
Leuti, A., Fazio, D., Fava, M., Piccoli, A., Oddi, S., & Maccarrone, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.028 · Cited by 358
Metabolic reprogramming in triple-negative breast cancer
Wang, Z., Jiang, Q., & Dong, C. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2019.0210 · Cited by 248
“…1 member B1 (AKR1B1) is activated in TNBC by Twist2, an inducer of EMT, and the accumulation of its major metabolite PGF2 α , in turn, activates NF-κ B signaling to upregulate Twist2 expression, which eventually forms a positive feedback loop to enhance the CSC properties in TNBC 88 ( Figure 2 ).”
BackgroundEpithelial plasticity, epithelial-mesenchymal transition, and the TGF-β family
Katsuno, Y., & Derynck, R. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.02.028 · Cited by 187
Metadata
- Authors
- Wu, X., Li, X., Fu, Q., Cao, Q., Chen, X., Wang, M., Yu, J., Long, J., Yao, J., Liu, H., Wang, D., Liao, R., & Dong, C.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2017-03-07
- Volume
- 214
- Issue
- 4
- Pages
- 1065-1079
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2593371615
- Cited by
- 154
- References
- 7
- FWCI
- 4.95
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program. https://app.cochat.ai/papers/10.1084/jem.20160903
- The paper
- Wu, X., Li, X., Fu, Q., Cao, Q., Chen, X., Wang, M., Yu, J., Long, J., Yao, J., Liu, H., Wang, D., Liao, R., & Dong, C. (2017). AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20160903
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.